is it safe to take tirzepatide while breastfeeding π¨ New Research Alert: & β What You Should Know! πΌ There's a lot of buzz right now about tirzepatide and breastfeeding β and for good reason. πΌβ¨ Many postpartum What Medications Are Safe While
Description
See who qualifies
Proactive monitoring, open conversations about emotional experience the goal remains integral patient care: treating the whole person, not just the symptom | 31 comments on LinkedIn
Aims/hypothesis The aim of this study was to evaluate the efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes insufficiently controlled with diet and exercise alone
Powered by MyLevel precision dosing.
In a significant milestone for type 2 diabetes care, Novo Nordisk has unveiled full results from its SOUL cardiovascular outcomes trial, confirming that oral semaglutide (14 mg) reduces the risk of major adverse cardiovascular events (MACE) by 14 per cent compared to placebo in adults with type 2 diabetes and existing cardiovascular and/or chronic kidney disease.The findings, presented at the American College of Cardiology's (ACC) Annual Scientific Session and Expo in Chicago, and simultaneously published in the New England Journal of Medicine, mark a major advancement in cardiometabolic treatment
Covers reconstitution, dosing schedule, and triple GLP-1/GIP/glucagon agonist weight loss cycle info.
